Redhill Biopharma Ltd (RDHL)

Redhill Biopharma Ltd experienced limited insider trading activity recently. Chief Operating Officer Gilead Raday executed a single sale valued at 1,431 USD. This transaction occurred amidst a 53.6% decline in stock price over the past ninety days, reflecting ongoing market volatility for the healthcare firm.
Ticker: RDHL Exchange: NAS


Loading...
• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Buy signal Sell signal Earnings
No insider activity signals detected

Insider trades have not triggered unusual activity signals for this company.

Top insiders
Trades
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Raday Gilead Chief Operating Officer Officer
Transaction date
Sale
Price
154.92
Quantity 23,735 +46.9%
Value US$3,798,289
Raday Gilead Chief Operating Officer Officer
Transaction date
Sale
Price
152.47
Quantity 35,693 +47.2%
Value US$3,191,897
Raday Gilead Chief Operating Officer Officer
Transaction date
Sale
Price
232.34
Quantity 57,003 +32.4%
Value US$4,817,785
Notification date Transaction date B/S Transaction type Insider and/or position Nb. shares
Price
Value
Number of shares Price Value Details
2026-10-06 2026-10-01 S Sale

Chief Operating Officer

Officer
23,735 +46.9%
154.92
US$3,798,289
23,735 +46.9% 154.92 US$3,798,289
2026-07-13 2026-07-10 S Sale

Chief Operating Officer

Officer
35,693 +47.2%
152.47
US$3,191,897
35,693 +47.2% 152.47 US$3,191,897
2026-04-22 2026-04-06 S Sale

Chief Operating Officer

Officer
57,003 +32.4%
232.34
US$4,817,785
57,003 +32.4% 232.34 US$4,817,785